Becoming a Partner of Choice and Evaluating Prospective Alliances

Jan Heybroek;David Wallis;

Publication

Article

February 15, 2003

BioPharm International

BioPharm International-02-01-2003

Volume16

Issue 2

Becoming a Partner of Choice and Evaluating Prospective Alliances

Author(s):

Jan Heybroek,David Wallis

by David Wallis, Dechert and Jan Heybroek Whether you're on the inlicensing or outlicensing side of a collaboration, attention must be paid to putting forth the right image and learning about your prospective partners before the alliance is struck.

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

Becoming a Partner of Choice and Evaluating Prospective Alliances

Using Amino Acid Analysis to Determine Absorptivity Constants: A Validation Case Study Using Bovine Serum Albumin

Guest Editorial: Maybe You Need a Corporate Marriage Counselor

Inside Washington: AIDS Prevention Campaign Spotlights Biotech

The Double Helix at 50: A Half Century of Innovation in the Words of Eight Distinguished Scientists

Survival Strategies: Keeping Tabs on Training

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Becoming a Partner of Choice and Evaluating Prospective Alliances

Newsletter